1. Home
  2. ENHA vs HQL Comparison

ENHA vs HQL Comparison

Compare ENHA & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enhanced Group Inc. Class A Common Stock

ENHA

Enhanced Group Inc. Class A Common Stock

N/A

Current Price

$1.57

Market Cap

632.1M

ML Signal

N/A

Logo abrdn Life Sciences Investors Shares of Beneficial Interest

HQL

abrdn Life Sciences Investors Shares of Beneficial Interest

HOLD

Current Price

$19.71

Market Cap

689.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENHA
HQL
Founded
N/A
1992
Country
Singapore
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Investment Managers
Sector
Consumer Discretionary
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
632.1M
689.4M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
ENHA
HQL
Price
$1.57
$19.71
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.3M
137.4K
Earning Date
N/A
01-01-0001
Dividend Yield
N/A
11.56%
EPS Growth
N/A
N/A
EPS
N/A
0.79
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$25.75
Revenue Growth
N/A
N/A
52 Week Low
$1.48
$13.88
52 Week High
$4.60
$22.67

Technical Indicators

Market Signals
Indicator
ENHA
HQL
Relative Strength Index (RSI) 30.19 36.86
Support Level $1.50 $16.21
Resistance Level $1.71 $21.32
Average True Range (ATR) 0.13 0.46
MACD 0.04 -0.24
Stochastic Oscillator 27.26 3.89

Price Performance

Historical Comparison
ENHA
HQL

About ENHA Enhanced Group Inc. Class A Common Stock

Enhanced Group Inc develops and sells sports and performance-related products intended for use by athletes and consumers. Its offerings focus on products associated with physical performance, health, and recovery. Its two principal offerings include: (i) the Enhanced Games, a live, multi-sport competition platform designed to showcase both "Enhanced" and "Non-Enhanced" athletes pursuing world-record performances under medically supervised conditions; and (ii) Live Enhanced, a direct-to-consumer digital and clinician-guided wellness platform offering evidence-based protocols, supplements, and coaching for consumers seeking to improve health, longevity, and well-being. The majority of the company's revenue is derived from products associated with physical performance, health, and recovery.

About HQL abrdn Life Sciences Investors Shares of Beneficial Interest

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.

Share on Social Networks: